Skip to content Skip to footer

Q2 in Review: Pharma’s Dealmaking Surge, a Wave of FDA Approvals, and AI’s Deepening Footprint 

A PharmaShots Quarterly Analysis  Q2 was one of the most active quarters in recent memory for the pharmaceutical and biotech industry. Big Pharma leaned hard into M&A and licensing to refill pipelines, the FDA cleared a broad slate of new therapies, and AI-native partnerships continued to reshape how drugs get discovered. Below, we break down the quarter…

Read more

CEAS Collective: Bridging Biotech Innovation and Consumer Wellness Through Direct-to-Patient Delivery 

Biotech innovation is rapidly transforming the boundaries of modern wellness, and CEAS  Collective stands at the forefront of this shift. By integrating advanced product  development with a direct-to-patient delivery model, CEAS Collective bridges the gap  between next-generation health solutions and consumer-centric care. Their approach  sets a new benchmark for accessible, holistic wellness, offering patients seamless  access to science-driven products…

Read more

Future Biotech Expo 2026 | June 02-03 | Hilton Houston North, TX, USA

The Future Biotech Expo is a premier international red biotechnology exhibition and conference dedicated to accelerating breakthroughs across the industry vertical that are shaping the future of healthcare and medicine across the globe and beyond.  Future Biotech Expo features a world-class exhibition, thought-provoking conferences, startup showcases, structured B2B matchmaking, and a dedicated Hosted Buyer Program…

Read more